Sandeep Dhall serves as the Director of Preclinical and Clinical Programs at Jaguar Gene Therapy, where he plays a pivotal role in advancing innovative therapies for genetic disorders. With a robust background in biochemistry and a keen understanding of both preclinical and clinical development processes,...
Sandeep Dhall serves as the Director of Preclinical and Clinical Programs at Jaguar Gene Therapy, where he plays a pivotal role in advancing innovative therapies for genetic disorders. With a robust background in biochemistry and a keen understanding of both preclinical and clinical development processes, Sandeep is at the forefront of leading critical projects such as JAG101 for Type 1 Galactosemia and JAG301 for Type 1 Diabetes. His multifaceted expertise allows him to seamlessly integrate consumer insights into actionable strategies, fostering strong relationships with key opinion leaders (KOLs) and stakeholders across the healthcare landscape.
In his current role, Sandeep is responsible for overseeing IND applications and coordinating experiments for clinical trials, ensuring that each phase of development is meticulously planned and executed. His scientific acumen is complemented by his proficiency in assay development and DNA extraction, which are essential for generating robust scientific data that informs payer and provider decisions. Sandeep's commitment to innovation is further evidenced by his successful patent applications, including one granted patent, showcasing his ability to conceptualize and translate scientific ideas into tangible products.
Moreover, Sandeep is a strong advocate for diversity and inclusion within the biotech field, recognizing the importance of varied perspectives in driving creativity and innovation. His leadership not only transforms scientific insights into viable therapeutic options but also cultivates an inclusive environment that empowers teams to excel. Through his dedication and expertise, Sandeep Dhall is making significant strides in the gene therapy landscape, paving the way for groundbreaking treatments that address unmet medical needs.
